Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:27 pm Purchase | 2021-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Point72 Asset Management, L.P. | 2,657,962 5.300% | 107,226 (+4.20%) | Filing History |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | Arcutis Biotherapeutics, Inc. ARQT | FMR LLC | 7,544,212 14.999% | 999,048 (+15.26%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT | BlackRock Inc. BLK | 4,313,864 8.600% | 1,418,810 (+49.01%) | Filing History |
| 2021-12-15 5:14 pm Purchase | 2021-12-14 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Point72 Asset Management, L.P. | 2,550,736 5.100% | 2,550,736 (New Position) | Filing History |
| 2021-05-12 5:27 pm Sale | 2021-05-10 | 13D | Arcutis Biotherapeutics, Inc. ARQT | Frazier Life Sciences VIII, L.P. | 8,481,907 16.900% | -2,084,883 (-19.73%) | Filing History |
| 2021-02-09 11:14 am Purchase | 2021-02-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT | Frazier Life Sciences VIII, L.P. | 10,566,790 21.700% | 24,000 (+0.23%) | Filing History |
| 2021-02-08 9:54 pm Unchanged | 2021-02-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT | ORBIMED ADVISORS LLC | 4,267,564 8.800% | 0 (Unchanged) | Filing History |
| 2021-02-08 5:00 pm Unchanged | 2021-02-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT | Bain Capital Life Sciences Fund, L.P. | 3,609,796 7.400% | 0 (Unchanged) | Filing History |
| 2021-02-08 10:15 am Purchase | 2021-02-05 | 13G | Arcutis Biotherapeutics, Inc. ARQT | FMR LLC | 6,545,164 14.999% | 2,486,155 (+61.25%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT | BlackRock Inc. BLK | 2,895,054 6.600% | 2,895,054 (New Position) | Filing History |